Randomized, controlled trial of metformin for obesity and insulin resistance in children and adolescents: Improvement in body composition and fasting insulin

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 6, 2006, Pages 2074-2080

  Srinivasan, Shubha ^a,b   Ambler, Geoffrey R ^a   Baur, Louise A ^b   Garnett, Sarah P ^a,b   Tepsa, Mirijana ^a   Yap, Fabian ^c   Ward, Glenn M ^d   Cowell, Christopher T ^a,b  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c KK WOMEN'S AND CHILDREN'S HOSPITAL   (Singapore)

^d ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; METFORMIN;

ADULT; ANTHROPOMETRY; ARTICLE; BODY COMPOSITION; BODY MASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SAFETY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GLUCOSE BLOOD LEVEL; HOSPITAL DEPARTMENT; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PRIORITY JOURNAL; PUBERTY; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SUBCUTANEOUS FAT; WAIST CIRCUMFERENCE;

ADOLESCENT; BODY COMPOSITION; BODY MASS INDEX; CHILD; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FASTING; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; METFORMIN; OBESITY; PATIENT COMPLIANCE;

EID: 33744959061     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-0241     Document Type: Article

References (40)

1. Jones KL, Arslanian S, Peterokova VA, Park JS, Tomlinson MJ 2002 Effect of metformin in pediatric patients with type 2 diabetes: a randomized controlled trial. Diabetes Care 25:89-94
2. Hamilton J, Cummings E, Zdravkovic V, Finegood D, Daneman D 2003 Metformin as an adjunct therapy in adolescents with type 1 diabetes and insulin resistance: a randomized controlled trial. Diabetes Care 26:138-143
3. Gomez R, Mokhashi MH, Rao J, Vargas A, Compton T, McCarter R, Chalew SA 2002 Metformin adjunctive therapy with insulin improves glycemic control in patients with type 1 diabetes mellitus: a pilot study. J Pediatr Endocrinol Metab 15:1147-1151
4. Sarnblad S, Kroon M, Aman J 2003 Metformin as additional therapy in adolescents with poorly controlled type 1 diabetes: randomised placebo-controlled trial with aspects on insulin sensitivity. Eur J Endocrinol 149:323-329
5. Ibanez L, de Zegher F 2003 Flutamide-metformin therapy to reduce fat mass in hyperinsulinemic ovarian hyperandrogenism: effects in adolescents and in women on third-generation oral contraception. J Clin Endocrinol Metab 88:4720-4724
6. Ibanez L, Ong K, Ferrer A, Amin R, Dunger D, de Zegher F 2003 Low-dose flutamide-metformin therapy reverses insulin resistance and reduces fat mass in nonobese adolescents with ovarian hyperandrogenism. J Clin Endocrinol Metab 88:2600-2606
7. Arslanian SA, Lewy V, Danadian K, Saad R 2002 Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance. J Clin Endocrinol Metab 87:1555-1559
8. Ibanez L, Valls C, Marcos MV, Ong K, Dunger DB, de Zegher F 2004 Insulin sensitization for girls with precocious pubarche and with risk for polycystic ovary syndrome: effects of prepubertal initiation and postpubertal discontinuation of metformin treatment. J Clin Endocrinol Metab 89:4331-4337
9. Schwimmer JB, Middleton MS, Deutsch R, Lavine JE 2005 A phase 2 clinical trial of metformin as a treatment for non-diabetic paediatric non-alcoholic steatohepatitis. Aliment Pharmacol Ther 21:871-879
10. Lutjens A, Smit JL 1977 Effect of biguanide treatment in obese children. Helv Paediatr Acta 31:473-480
11. Kay JP, Alemzadeh R, Langley G, D'Angelo L, Smith P, Holshouser S 2001 Beneficial effects of metformin in normoglycemic morbidly obese adolescents. Metabolism 50:1457-1461
12. Freemark M, Bursey D 2001 The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes. Pediatrics 107:E55
13. Morrison JA, Cottingham EM, Barton BA 2002 Metformin for weight loss in pediatric patients taking psychotropic drugs. Am J Psychiatry 159:655-657
14. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH 2000 Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 320:1240-1243
15. Quon MJ 2001 Limitations of the fasting glucose to insulin ratio as an index of insulin sensitivity. J Clin Endocrinol Metab 86:4615-4617
16. 2005 CDC growth charts for the United States. Methods and Development. www.cdc.gov/nchs/data/series/sr_11/sr11_246.pdf. Accessed April 2005
17. Fernandez JR, Redden DT, Pietrobelli A, Allison DB 2004 Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents. J Pediatr 145:439-444
18. Tanner JM, Whitehouse RH 1976 Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child 51:170-179
19. Burke JP, Hale DE, Hazuda HP, Stern MP 1999 A quantitative scale of acanthosis nigricans. Diabetes Care 22:1655-1659
20. Bergman RN, Ider YZ, Bowden CR, Cobelli C 1979 Quantitative estimation of insulin sensitivity. Am J Physiol 236:E667-E677
21. Pocock S 1983 Crossover trials. Clinical trials: a practical approach. Chichester, NY: John Wiley and Sons; 110-122
22. Garber AJ 2000 Using dose-response characteristics of therapeutics agents for treatment decisions in type 2 diabetes. Diabetes Obes Metab 2:139-147
23. Osterberg L, Blaschke T 2005 Adherence to medication. N Engl J Med 353:487-497
24. Weiss R, Taksali SE, Dufour S, Yeckel CW, Papademetris X, Cline G, Tamborlane WV, Dziura J, Shulman GI, Caprio S 2005 The "obese insulin-sensitive" adolescent: importance of adiponectin and lipid partitioning. J Clin Endocrinol Metab 90:3731-3737
25. Rodriguez G, Moreno LA, Blay MG, Blay VA, Garagorri JM, Sarria A, Bueno M 2004 Body composition in adolescents: measurements and metabolic aspects. Int J Obes Relat Metab Disord 28(Suppl 3):S54-S58
26. Park HS, Lee K 2005 Greater beneficial effects of visceral fat reduction compared with subcutaneous fat reduction on parameters of the metabolic syndrome: a study of weight reduction programmes in subjects with visceral and subcutaneous obesity. Diabet Med 22:266-272
27. Monzillo LU, Hamdy O 2003 Evaluation of insulin sensitivity in clinical practice and in research settings. Nutr Rev 61:397-412
28. Grant DB 1967 Fasting serum insulin levels in childhood. Arch Dis Child 42:375-378
29. Bloch CA, Clemons P, Sperling MA 1987 Puberty decreases insulin sensitivity. J Pediatr 110:481-487
30. Travers SH, Jeffers BW, Bloch CA, Hill JO, Eckel RH 1995 Gender and Tanner stage differences in body composition and insulin sensitivity in early pubertal children. J Clin Endocrinol Metab 80:172-178
31. Goran MI, Gower BA 2001 Longitudinal study on pubertal insulin resistance. Diabetes 50:2444-2450
32. Moran A, Jacobs Jr DR, Steinberger J, Hong CP, Prineas R, Luepker R, Sinaiko AR 1999 Insulin resistance during puberty: results from clamp studies in 357 children. Diabetes 48:2039-2044
33. Caprio S, Plewe G, Diamond MP, Simonson DC, Boulware SD, Sherwin RS, Tamborlane WV 1989 Increased insulin secretion in puberty: a compensatory response to reductions in insulin sensitivity. J Pediatr 114:963-967
34. Cusi K, Consoli A, DeFronzo RA 1996 Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 81:4059-4067
35. Gunton JE, Delhanty PJ, Takahashi S, Baxter RC 2003 Metformin rapidly increases insulin receptor activation in human liver and signals preferentially through insulin-receptor substrate-2. J Clin Endocrinol Metab 88:1323-1332
36. Bailey CJ, Turner RC 1996 Metformin. N Engl J Med 334:574-579
37. Perriello G, Misericordia P, Volpi E, Santucci A, Santucci C, Ferrannini E, Ventura MM, Santeusanio F, Brunetti P, Bolli GB 1994 Acute antihyperglycemic mechanisms of metformin in NIDDM. Evidence for suppression of lipid oxidation and hepatic glucose production. Diabetes 43:920-928
38. Ibanez L, de Zegher F 2005 Flutamide-metformin plus ethinylestradiol- drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of metformin at the start and after more than one year of therapy. J Clin Endocrinol Metab 90:39-43
39. Ibanez L, Fucci A, Valls C, Ong K, Dunger D, de Zegher F 2005 Neutrophil count in small-for-gestational age children: contrasting effects of metformin and growth hormone therapy. J Clin Endocrinol Metab 90:3435-3439
40. Boston RC, Stefanovski D, Moate PJ, Sumner AE, Watanabe RM, Bergman RN 2003 MINMOD Millenium: a computer program to calculate glucose effectiveness and insulin sensitivity from the frequently sampled intravenous glucose tolerance test. Diabetes Technol Ther 5:1003-1015